Neonatal cardiac failure

47
Neonatal cardiac failure- Pathophysiological basis Dr.Gopakumar Hariharan Senior Registrar, Neonatal and Paediatric Intensive care

Transcript of Neonatal cardiac failure

Page 1: Neonatal cardiac failure

Neonatal cardiac failure- Pathophysiological basis

Dr.Gopakumar Hariharan

Senior Registrar,

Neonatal and Paediatric Intensive care

Page 2: Neonatal cardiac failure

Neonatal cardiac failure

• Case scenario

• Fetal circulation and neonatal heart

• Pathophysiology

• Basis of Management

Page 3: Neonatal cardiac failure

Case scenario

• Ex 31 weeker, now corrected age 38 weeks

• Holt Oram syndrome – Hypoplastic radius and Cardiac defect – Large AVSD

• Initial management for respiratory distress syndrome

• Prolonged non invasive respiratory support

• Cardiac failure – Frusemide and Captopril

• Transfer to Melbourne for definitive surgery

Page 4: Neonatal cardiac failure

Challenges with Neonatal cardiac failure

• Unique anatomic and physiologic factors

• Different etiologies of cardiac failure

• Functional and structural differences between mature and immature myocardium

Page 5: Neonatal cardiac failure

Fetal circulation

Page 6: Neonatal cardiac failure

Postnatal transition and congenital heart defects

Cord clamping – increase in SVR

PVR decreases

PDA shunts from left to right ( functionally closes by 12 hours of life – Mediated by oxygen, bradykinins and nitric oxide)

Blood flow to the left atrium increased substantially through the pulmonary veins.

Left atrium pressure increases - septum primum apposes the crista, resulting in closure of foramen ovale

Heyman MA,Rudolph AM. Effects of congenital heart diseaseon fetal and neonatal circulations.Prog Cardiovasc Dis.1972;15:115-143

Page 7: Neonatal cardiac failure

Reduction in PVR

• Fall in PVR- contributed by improved ventilation and oxygenation

• Increase in oxygenation - modest increase in pulmonary blood flow and decrease in mean pulmonary artery pressure.

• Oxygen modulates the production of the vasoactive substances nitric oxide and prostacyclin

Page 8: Neonatal cardiac failure

Neonatal cardiac failure - etiology

• Systolic Vs Diastolic

• Right sided Vs Left sided

• Low output Vs High output

Page 9: Neonatal cardiac failure

Pathophysiology – Atrioventricular septal defect

Page 10: Neonatal cardiac failure

Atrioventricular septal defect

Large VSD•Equalisation of Right and left ventricular pressures•Left to right shunt •Large pulmonary blood flow into lungs •Pulmonary hypertension

Primum ASD

•Left to right shunt •Volume load on right ventricle

AV valve regurgitation •Volume loading of left atrium and left ventricle •Decreased left ventricular compliance •Increase in left to right shunting at atrial level

Normal physiologic nadir of the infant hematocrit first 30-60 days of life, - further decrease in the pulmonary vascular resistance causes additional left to right shunting and the resulting pulmonary overcirculation.

Cardiac failure

Page 11: Neonatal cardiac failure

Compensatory mechanisms

Page 12: Neonatal cardiac failure

Counterregulatory neurohormones in Cardiac failure – Vicious cycle in impaired heart

Renin- Angiotensin aldosterone mechanism•Retain sodium and water•Increase intravascular volume and preload

Increased sympathetic activation•Vasoconstriction of arteries•Increased afterload

Incraesed sympathetic activation •Increased contractility

Page 13: Neonatal cardiac failure

Frank Starling Principle

If the initial (resting) length of (i) Either an individual myocardial cell (or ) (ii) Whole of ventricle Is incr. WITH IN LIMITS

The force generated by the contractile Fibers (or) cardiac output as a whole increases

Page 14: Neonatal cardiac failure

Frank starling forces

Kirkpatrick SE, Pitlick PT, Naliboff J, Friedman WF (1976) Frank-Starling relationship as an important determinant of fetal cardiac output. Am J Physiol 231:495-500.

Page 15: Neonatal cardiac failure

Neonatal myocardium

• Left ventricular mass increase in postnatal period – initially hyperplasia and later hyperplastic

• Myocyte proliferation occurs more rapidly in the left than the right – due to increased demands of a high vascular resistance

• myocyte hypertrophy accounts for most of the increase in ventricular mass subsequently ( mediated by increased work load, circulating growth factors and catacholamines).

• Acidic fibroblast growth factors and transforming growth factors produced by the cardiac myocyte may mediate cellular proliferation and differentiation.

Page 16: Neonatal cardiac failure

Neonatal myocyte

Rounded, relatively short and quite disorganized intracellulary

Myofibrils- contractile proteins

Mature cells- myofibrils densily concentrated and are aligned in parallel with the axis of the cell, organized into alternating rows of mitochondria

Neonates- myofibrils less dense and more likely to be situated along the periphery of the cell . The more central portion is made up of disorganized clumps of mitochondria and nuclei

Page 17: Neonatal cardiac failure

Inefficient Myocardial contractility

• Less complaint

• Generate less contractile force

• Inefficiently shaped and less organized myofibrils

• Greater ratio of noncontractile elements to contractile units

Page 18: Neonatal cardiac failure

So.. Why is our baby working hard

Page 19: Neonatal cardiac failure

Contributory Factors

• Premature lungs

• Preterm infants develop symptoms earlier as their PVR is lower due to inadequate mascularisation of the pulmonary arteries

• Increased preload from Neurohumeral mechanisms

• Increased afterload from high Sympathetic activity

• Insufficient ventricular contractility

Page 20: Neonatal cardiac failure

Circulatory adaptation in cardiac failure ( in context of pulmonary overcirculation)

• Activation of sympathetic nervous system – increase in plasma norepinephrine

• Stimulation of renin- angiotensin- aldosterone system

• Increase in plasma arginine vasopressin

• Increased atrial natriuretic peptides – from atrial stretch from volume/ pressure overload

• Peripheral vasoconstriction

• Increased heart rate

• Water retension

Page 21: Neonatal cardiac failure

Chest X ray

Page 22: Neonatal cardiac failure

Goals of management

• Provide symptomatic relief

• Correct metabolic abnormalities

• Reverse haemodynamic derangements

Page 23: Neonatal cardiac failure

Decreased myocardial contractility

• Unload myocardium with diuretics

• Reduce afterload

Page 24: Neonatal cardiac failure

Medical management

Page 25: Neonatal cardiac failure

Diuretics

• Initial treatment in decompensated cardiac failure

• Diuretic resistance – add intravenous thiazide diuretics( chlorthiazide)

• Continuous loop diuretic infusion

Monitoring • Electrolyte disturbance – profound

urinary loss of potassium, magnesium and calcium due to immature renal secretory control in neonates

• Renal insufficiency

• Hypotension

Page 26: Neonatal cardiac failure
Page 27: Neonatal cardiac failure

• 117

• premature infants

• 20 had intrarenal calcification

• 2 required nephrolithotomy

• 4 had recurrent UTI

• Discontinuation- results in resolution of calcification

• Continued treatment with Frusemide- Associated with renal morbidity

Page 28: Neonatal cardiac failure

• 27 babies less than 1500 grams.3 groups

A) No Frusemide and no calcification

B) Frusemide and no calcification

C) Frusemide and calcification

• No abnormalities in renal function in group A and B

• Higher calcium creatinine ratios, increased fractional excretion of sodium and lower tubular absorption of Phosphate in group C

• Possible glomerular and tubular dysfunction

Page 29: Neonatal cardiac failure
Page 30: Neonatal cardiac failure

Afterload in cardiac failure

Afterload – Little effect on normal ventricle

systolic failure – even small increases in afterload have significant effects.

Small reductions in afterload in a failing ventricle can have significant beneficial effects on impaired contractility

Page 31: Neonatal cardiac failure

ACE inhibitors

• Inhibits formation of Angiotensin II ( Potent vasoconstrictor, promotes aldosterone release and facilitates sympathetic activity)

• Inhibition results in accumulation of kinins like bradykinin- promotes vasodilator activity

Page 32: Neonatal cardiac failure

Age range- as early as 6 days

Initial median dose – 0.1mg/kg(0.05to 0.55mg/kg/day)

Additionally treated with Frusemide

Sideeffects in 17 patients of 43a) Renal impairement/ failureb) Hypotension

All side effects reversible

Side effects not dose related

Page 33: Neonatal cardiac failure

Deficient Calcium transport mechanism – ? Role for calcium

• Cardiac myocyte membrane(sarcolemma) – has ion channels and pumps- allows transport of calcium and other ions

• Immature heart- more dependent on extracellular calcium for myocardial contraction

• Sarcoplasmic reticulum of fetal sheep- low density of calcium channels and decreased pump activity

• Importance- Frusemide and calcium loss??

Page 34: Neonatal cardiac failure
Page 35: Neonatal cardiac failure

NETS- Challenges

Page 36: Neonatal cardiac failure

Fluid management

Left ventricular filling volume is reduced beyond a particular pressure( lesser in magnitude than adult)- smaller boluses

Spotnitz WD, Spotnitz HM, Truccone NJ (et al) (1979) Relation of ultrastructure and function. Sarcomere dimensions, pressure-volume curves, and geometry of the intact left ventricle of the immature canine heart. Circ Res 44:679-691

Page 37: Neonatal cardiac failure

Fluid management- concept of ventricular interdependence

Filling of one ventricle reducing the distensibility of the opposite ventricle

More profound in fetus than adults

Little change in cardiac output when the immature ventricle is volume loaded

Romero T, Covell J, Friedman WF (1972) A comparison of pressure-volume relations of the fetal, newborn, and adult heart. Am J Phys 222:1285-1290.

Page 38: Neonatal cardiac failure

NETS

• Respiratory support – CPAP

• Anticipation of increased oxygen requirement

• Intravenous diuretics

• Nasogastric tube for venting

Page 39: Neonatal cardiac failure

Surgical managementA medical perspective

Page 40: Neonatal cardiac failure

Evaluation

TAR – hematology for thrombocytopenia

Holtoram- Kidneys , heart scans

Vateryl

Page 41: Neonatal cardiac failure

Radial hypoplasia

Page 42: Neonatal cardiac failure

Thumb hypoplasia

• Pollicisation - converts index finger into thumb – prehensile hand with a thumb and three fingers – improved function and appearance

• Toe to hand transfer( second toe) – excellent improvement in function and appearance

• Role for physiotherapist and occupational therapist

• Therapy ideally started in the neonatal period- especially with restricted interphalangeal joint extension

• Gain in length – distraction techniques

Page 43: Neonatal cardiac failure

(A) Child with pollicisation of the index finger to make a thumb.

Watson S Arch Dis Child 2000;83:10-17

Copyright © BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health. All rights reserved.

Page 44: Neonatal cardiac failure

Radial club hand

• Therapy, splints and stretching should start in the neonatal period

• Distal radial hypoplasia responds well to treatment

• Severe from- absence with forearm at right angles – no major respose

• Hypoplastic thumbs- stabilized and given more movements by tendon transfers

Page 45: Neonatal cardiac failure

Questions

Page 46: Neonatal cardiac failure

Summary

• Neonatal Myocardium anatomically different

• Complex pathology

• Pathophysiological understanding to direct treatment

Page 47: Neonatal cardiac failure

Thank You